"Ipratropium" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic.
| Descriptor ID |
D009241
|
| MeSH Number(s) |
D02.145.074.722.229.400 D03.132.760.180.572.400 D03.132.889.180.648.400 D03.605.084.500.722.229.400 D03.605.869.229.400
|
| Concept/Terms |
Ipratropium- Ipratropium
- (endo,syn)-(+-)-3-(3-Hydroxy-1-oxo-2-phenylpropoxy)-8-methyl-8-(1-methylethyl)-8-azoniabicyclo(3.2.1)octane
- N-Isopropylatropine
- N Isopropylatropine
Ipratropium Bromide- Ipratropium Bromide
- Ipratropium Bromide Monohydrate
- Bromide Monohydrate, Ipratropium
- Monohydrate, Ipratropium Bromide
|
Below are MeSH descriptors whose meaning is more general than "Ipratropium".
Below are MeSH descriptors whose meaning is more specific than "Ipratropium".
This graph shows the total number of publications written about "Ipratropium" by people in this website by year, and whether "Ipratropium" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2012 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Ipratropium" by people in Profiles.
-
Harer K, Alverson B. Eye-opening Etiologies. Hosp Pediatr. 2018 05; 8(5):300-301.
-
Singh S, Loke YK, Enright P, Furberg CD. Republished: pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications. Postgrad Med J. 2014 Apr; 90(1062):205-7.
-
Singh S, Loke YK, Enright P, Furberg CD. Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications. Thorax. 2013 Jan; 68(1):114-6.
-
Singh S, Loke YK, Furberg CD. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA. 2008 Sep 24; 300(12):1439-50.
-
Taylor MK, Hickey AJ, VanOort M. Manufacture, characterization, and pharmacodynamic evaluation of engineered ipratropium bromide particles. Pharm Dev Technol. 2006; 11(3):321-36.
-
Bird SB, Gaspari RJ, Dickson EW. Early death due to severe organophosphate poisoning is a centrally mediated process. Acad Emerg Med. 2003 Apr; 10(4):295-8.